A detailed history of Vestcor Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Vestcor Inc holds 20,148 shares of COLL stock, worth $926,405. This represents 0.02% of its overall portfolio holdings.

Number of Shares
20,148
Previous 21,531 6.42%
Holding current value
$926,405
Previous $637,000 10.68%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$29.75 - $39.59 $41,144 - $54,752
-1,383 Reduced 6.42%
20,148 $705,000
Q2 2025

Aug 08, 2025

BUY
$24.67 - $30.44 $460,638 - $568,375
18,672 Added 653.1%
21,531 $637,000
Q1 2025

May 08, 2025

SELL
$28.04 - $33.91 $384,680 - $465,211
-13,719 Reduced 82.75%
2,859 $85,000
Q4 2024

Feb 10, 2025

BUY
$28.61 - $41.86 $400,253 - $585,621
13,990 Added 540.57%
16,578 $475,000
Q3 2023

Nov 14, 2023

BUY
$21.23 - $24.28 $54,943 - $62,836
2,588 New
2,588 $58,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.57B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.